Medical and Pharmaceutical Ultragenyx plunges after-hours from rare disease drug trial failure Angelman syndrome is a rare genetic nervous system disorder causing severe developmental delay Rowan DunneSeptember 3, 2026
Medical and Pharmaceutical bioAffinity jumps 45% from lung cancer phlegm test expansion It is the only commercially available test of its kind Rowan DunneSeptember 2, 2026
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan DunneAugust 28, 2026
Cannabis Pakistani cabinet approves national framework for medical cannabis regulation The move builds on Pakistan's decision to legalize industrial hemp and medical cannabis in 2020 Rowan DunneJanuary 26, 2026
Cannabis Lebanon starts implementing medical cannabis legalization framework The Middle Eastern nation expects a US$1B annual boost to the state treasury Rowan DunneOctober 30, 2025
Psychedelics Pharma giant AbbVie to spend over US$1B on Gilgamesh’s lead psychedelic One of the biggest deals of all time in the industry Rowan DunneAugust 27, 2025
Medical and Pharmaceutical Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment The stock was up by about 200% during early trading hours Rowan DunneFebruary 6, 2025
Medical and Pharmaceutical BioAge Labs craters after dropping clinical study on top drug candidate for obesity Usage of the therapeutic resulted in unhealthy levels of transaminases (liver enzymes) in participants Rowan DunneDecember 9, 2024
Medical and Pharmaceutical Kentucky governor recognizes Lung Cancer Awareness Month with formal proclamation Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers Rowan DunneNovember 26, 2024